Skip To Main Content
Julia Barnes-Weise on Muck Rack

Julia Barnes-Weise

As seen in: HuffPost, Journal of Epidemiology and Community Health, STAT, Think Global Health
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Julia

Contact Julia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Public investment in the development of vaccines: making them equitably available for the world

|
By Julia Barnes-Weise, Laura Hoemeke, Bridie Telford
| bmj.com
Dear editor, The Policy Solutions section of this paper introduces important considerations for actions to support equitable access to publicly funded vaccines and other medical products. Several recent articles [1] have similarly proposed attaching access-related conditions to public funding.
Open in Who Shared Issue with article?

Building COVID-19 Vaccine Production Capacity in LMICs

|
By Reid Adler, Julia Barnes-Weise, Ana Santos Rutschman, Bridie Telford
| Think Global Health
by Reid Adler, Julia Barnes-Weise, Ana Santos Rutschman, Bridie Telford May 26, 2022 Many low- and middle-income countries (LMICs) did not have access to COVID-19 vaccines when they first needed them. LMICs that were reliant on donations or distributions from COVAX experienced substantial time lags in the conversion of donation pledges to delivered doses.
Open in Who Shared Issue with article?

Assessment of the proposed intellectual property waiver as a mechanism to address the COVID-19 vaccine scarcity problem

|
By Julia Barnes-Weise, Ana Santos Rutschman, Reid Adler, Johns Hopkins
| Journal of Epidemiology and Community Health Verified
The proposed intellectual property waiver Throughout 2021, one type of potential solution to vaccine scarcity has gained momentum across the international community: a waiver of intellectual property rights covering certain products needed in the response to COVID-19.
Open in Who Shared Issue with article?
See all 6 licensed articles (8 Total)